1. Home
  2. IDR vs KMDA Comparison

IDR vs KMDA Comparison

Compare IDR & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Idaho Strategic Resources Inc.

IDR

Idaho Strategic Resources Inc.

HOLD

Current Price

$31.18

Market Cap

502.0M

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.74

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDR
KMDA
Founded
1996
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.0M
460.3M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
IDR
KMDA
Price
$31.18
$7.74
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
205.7K
74.9K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
70.15
N/A
EPS
0.63
N/A
Revenue
$42,406,253.00
N/A
Revenue This Year
$25.52
$13.94
Revenue Next Year
N/A
$9.84
P/E Ratio
$50.70
$24.59
Revenue Growth
64.59
N/A
52 Week Low
$22.31
$6.50
52 Week High
$54.70
$9.35

Technical Indicators

Market Signals
Indicator
IDR
KMDA
Relative Strength Index (RSI) 46.98 63.79
Support Level $27.46 $7.66
Resistance Level $41.05 $8.55
Average True Range (ATR) 1.82 0.20
MACD 0.23 0.07
Stochastic Oscillator 41.09 87.68

Price Performance

Historical Comparison
IDR
KMDA

About IDR Idaho Strategic Resources Inc.

Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. The Company's primary business is exploring for, developing, and extracting gold, and to a lesser extent, silver, and base metal mineral resources in the greater Coeur d'Alene Mining District of North Idaho. The Company produces gold at the Golden Chest Mine located in the Murray Gold Belt area of the world-class Coeur d'Alene Mining District, north of the prolific Silver Valley.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: